134 related articles for article (PubMed ID: 37442377)
21. A Rare Case of Pembrolizumab-Induced Uveitis in a Patient with Metastatic Melanoma.
Hanna KS
Pharmacotherapy; 2016 Nov; 36(11):e183-e188. PubMed ID: 27716999
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristics and Treatment of 308 Panuveitis Patients over 10 Years: Results from the KKESH Uveitis Survey Study Group.
Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Shamsi HN; Al Suliman SM; Al Rushood AA; Al-Zahrani YA; Al-Mahmood AM; Al Dhibi HA;
Ocul Immunol Inflamm; 2019; 27(8):1296-1304. PubMed ID: 30303435
[No Abstract] [Full Text] [Related]
23. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
[TBL] [Abstract][Full Text] [Related]
24. Tuberculous uveitis after treatment with etanercept.
Fonollosa A; Segura A; Giralt J; Garcia-Arumi J
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1397-9. PubMed ID: 17364199
[TBL] [Abstract][Full Text] [Related]
25. Bilateral Granulomatous Panuveitis in A Patient with COVID-19.
Ozdemir Yalcinsoy K; Ozdamar Erol Y; Ozdal PC
Ocul Immunol Inflamm; 2023 Aug; 31(6):1206-1209. PubMed ID: 35486665
[TBL] [Abstract][Full Text] [Related]
26. Targeted Medical History and Diagnostic Testing in Uveitis.
Grajewski RS; Tappeiner C; Thurau S
Klin Monbl Augenheilkd; 2022 May; 239(5):654-658. PubMed ID: 35320872
[TBL] [Abstract][Full Text] [Related]
27. Case Report: Recurrent Severe Uveitis Secondary to Primary Progressive Multiple Sclerosis Responsive to Ocrelizumab.
Guo B; Little M
Ocul Immunol Inflamm; 2023 Jan; 31(1):188-190. PubMed ID: 34735301
[TBL] [Abstract][Full Text] [Related]
28. Extranodal natural killer/T-cell lymphoma presenting as hypopyon panuveitis: a case report.
Sukon N; Tesavibul N; Choopong P; Panyayingyong N; Boonsopon S
BMC Ophthalmol; 2022 Feb; 22(1):46. PubMed ID: 35100995
[TBL] [Abstract][Full Text] [Related]
29. Panuveitis as presenting sign of chickenpox in a young child.
Belfair N; Levy J; Lifshitz T
Can J Ophthalmol; 2006 Feb; 41(1):97-9. PubMed ID: 16462882
[TBL] [Abstract][Full Text] [Related]
30. Post-Streptococcal Uveitis: Case Report.
Medina CA; Fajardo A; Calderon A; Aracena M
Ocul Immunol Inflamm; 2019; 27(7):1086-1089. PubMed ID: 30081680
[No Abstract] [Full Text] [Related]
31. Infectious causes of posterior uveitis and panuveitis in Thailand.
Kongyai N; Pathanapitoon K; Sirirungsi W; Kunavisarut P; de Groot-Mijnes JD; Rothova A
Jpn J Ophthalmol; 2012 Jul; 56(4):390-5. PubMed ID: 22539102
[TBL] [Abstract][Full Text] [Related]
32. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
[TBL] [Abstract][Full Text] [Related]
33. [Semiology and classification of uveitis].
Brézin AP
Rev Prat; 1999 Nov; 49(18):1982-8. PubMed ID: 10626482
[TBL] [Abstract][Full Text] [Related]
34. Corticosteroid implants for chronic non-infectious uveitis.
Reddy A; Liu SH; Brady CJ; Sieving PC; Palestine AG
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD010469. PubMed ID: 37642198
[TBL] [Abstract][Full Text] [Related]
35. Panuveitis simulating ocular Behçet's in cases of chronic myelogenous leukaemia in remission.
Chawla R; Tripathy K
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170182
[TBL] [Abstract][Full Text] [Related]
36. Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.
Lopalco G; Venerito V; Sota J; Rigante D; Guerriero S; Orlando I; Franceschini R; Favale R; Lapadula G; Castelli B; Frediani B; Galeazzi M; La Torre F; Iannone F; Tosi GM; Fabiani C; Cantarini L
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):68-73. PubMed ID: 30582503
[TBL] [Abstract][Full Text] [Related]
37. A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination.
Ogino Y; Namba K; Iwata D; Suzuki K; Mizuuchi K; Hiraoka M; Kitaichi N; Ishida S
BMC Ophthalmol; 2023 May; 23(1):233. PubMed ID: 37226110
[TBL] [Abstract][Full Text] [Related]
38. Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes.
Dow ER; Yung M; Tsui E
Ocul Immunol Inflamm; 2021 Jan; 29(1):203-211. PubMed ID: 32815757
[No Abstract] [Full Text] [Related]
39. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R; Testi I; Bodaghi B; Barisani-Asenbauer T; McCluskey P; Agarwal A; Kempen JH; Gupta A; Smith JR; de Smet MD; Yuen YS; Mahajan S; Kon OM; Nguyen QD; Pavesio C; Gupta V;
Ophthalmology; 2021 Feb; 128(2):277-287. PubMed ID: 32603726
[TBL] [Abstract][Full Text] [Related]
40. Bilateral Panuveitis Associated with Morvan Syndrome: A Case Report and Review of the Literature.
Kryshtalskyj MT; Devenyi RG; Roy M
Ocul Immunol Inflamm; 2023 May; 31(4):851-855. PubMed ID: 35404744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
